4.5 Article Proceedings Paper

Modeling between-trial variance structure in mixed treatment comparisons

期刊

BIOSTATISTICS
卷 10, 期 4, 页码 792-805

出版社

OXFORD UNIV PRESS
DOI: 10.1093/biostatistics/kxp032

关键词

Bayesian hierarchical model; Between-trial heterogeneity; Equivalent prior sample method; Evidence consistency; Markov chain Monte Carlo; Mixed treatment comparison meta-analysis; Triangle inequality

资金

  1. MRC [MC_U145079307, G0800800] Funding Source: UKRI
  2. Medical Research Council [MC_U145079307, G0800800] Funding Source: Medline
  3. Medical Research Council [MC_U145079307, G0800800] Funding Source: researchfish

向作者/读者索取更多资源

In mixed treatment comparison (MTC) meta-analysis, modeling the heterogeneity in between-trial variances across studies is a difficult problem because of the constraints on the variances inherited from the MTC structure. Starting from a consistent Bayesian hierarchical model for the mean treatment effects, we represent the variance configuration by a set of triangle inequalities on the standard deviations. We take the separation strategy (Barnard and others, 2000) to specify prior distributions for standard deviations and correlations separately. The covariance matrix of the latent treatment arm effects can be employed as a vehicle to load the triangular constraints, which in addition allows incorporation of prior beliefs about the correlations between treatment effects. The spherical parameterization based on Cholesky decomposition (Pinheiro and Bates, 1996) is used to generate a positive-definite matrix for the prior correlations in Markov chain Monte Carlo (MCMC). Elicited prior information on correlations between treatment arms is introduced in the form of its equivalent data likelihood. The procedure is implemented in a MCMC framework and illustrated with example data sets from medical research practice.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据